跳至主要内容
临床试验/NCT07037706
NCT07037706已完成不适用

Use of Macrolides in Acute Chest Syndrome: A Multicenter Retrospective Study

Centre Hospitalier de Saint-Denis1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
250
试验地点
1
主要终点
Duration of mechanical ventilation (in days) among patients with ACS treated with empiric macrolides

研究概览

简要总结

This study looks at whether using macrolide antibiotics is helpful and safe in treating acute chest syndrome, a serious complication in people with sickle cell disease. It reviews past cases from three hospitals where patients were treated in intensive care. The goal is to understand if macrolides make a difference, what germs are involved, how useful lab tests are, and how well patients tolerate these antibiotics.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient (≥18 years old).
  • Diagnosis of acute chest syndrome (ACS).
  • Hospitalized in an intensive care unit (ICU).
  • Microbiological sampling performed (e.g., multiplex PCR, sputum culture [ECBC], and/or Legionella urinary antigen test).
  • Received empiric antibiotic therapy including a macrolide.

排除标准

  • Minor patient (<18 years old).
  • Acute chest syndrome not requiring ICU admission.
  • Acute chest syndrome without any attempt at microbiological documentation.

结局指标

主要结局

Duration of mechanical ventilation (in days) among patients with ACS treated with empiric macrolides

时间窗: 28 days

次要结局

未报告次要终点

研究者

发起方
Centre Hospitalier de Saint-Denis
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验